Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam

We report a low incidence of HCV reinfection following treatment in DU participating in a multidisciplinary programme. Active drug use, including injecting, should not preclude access to treatment for HCV.